Risk of new-onset and recurrent uveitis with different biologics for ankylosing spondylitis: a network meta-analysis
BackgroundUveitis is a common extra-articular manifestation of ankylosing spondylitis (AS), and a systematic analysis of the effects of biologics on new-onset and recurrent uveitis is clinically important.MethodsWe conducted a network meta-analysis (NMA) to assess the impact of anti-TNF-α (adalimuma...
Saved in:
| Main Authors: | Xu Zhao, Qingqing Xie, Xinyi He, Yiwei Lu, Menglan Li, Shiquan Shuai |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-06-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1556313/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Course of uveitis in patients with ankylosing spondylitis during the interleukin 17 inhibitors therapy
by: A. A. Godzenko, et al.
Published: (2023-10-01) -
Efficacy of golimumab in treating uveitis in patients with ankylosing spondylitis
by: T. V. Dubinina, et al.
Published: (2016-09-01) -
IMPACT OF THE THERAPY WITH TUMOR NECROSIS FACTOR α INHIBITORS ON THE FREQUENCY OF UVEITIS EXACERBATIONS IN PATIENTS WITH ANKYLOSING SPONDYLITIS
by: Alla A Godzenko, et al.
Published: (2014-03-01) -
COURSE OF UVEITIS IN PATIENTS WITH ANKYLOSING SPONDYLITIS
by: A. A. Godzenko, et al.
Published: (2016-09-01) -
Retention rate of TNF inhibitors versus IL-17 inhibitors in ankylosing spondylitis patients with prior biologics experience
by: Jiwon Yang, et al.
Published: (2025-07-01)